Abstract
Transbronchial needle aspiration biopsy (TBNA) was developed in the 1980’s as a technique for mediastinal and hilar lymph node biopsy. This offered pulmonologists and patients a minimally invasive technique for mediastinal non-small cell lung cancer staging and served as an alternative to surgical mediastinoscopy. Over the last few decades there are new additions to this technique using guided TBNA with endobronchial ultrasound (EBUS) and the use navigational bronchoscopy for peripheral lung TBNA. The future of TBNA may potentially transition from a diagnostic tool to a therapeutic instrument by locally injecting medications.
Keywords: Bronchoscopy, transbronchial needle aspiration.
Current Respiratory Medicine Reviews
Title:Transbronchial Needle Aspiration (TBNA): Past Present and Future
Volume: 10 Issue: 3
Author(s): C. Gilbert, R. Ortiz, Y. Ma, H.J. Lee, L. Yarmus and K. Wang
Affiliation:
Keywords: Bronchoscopy, transbronchial needle aspiration.
Abstract: Transbronchial needle aspiration biopsy (TBNA) was developed in the 1980’s as a technique for mediastinal and hilar lymph node biopsy. This offered pulmonologists and patients a minimally invasive technique for mediastinal non-small cell lung cancer staging and served as an alternative to surgical mediastinoscopy. Over the last few decades there are new additions to this technique using guided TBNA with endobronchial ultrasound (EBUS) and the use navigational bronchoscopy for peripheral lung TBNA. The future of TBNA may potentially transition from a diagnostic tool to a therapeutic instrument by locally injecting medications.
Export Options
About this article
Cite this article as:
Gilbert C., Ortiz R., Ma Y., Lee H.J., Yarmus L. and Wang K., Transbronchial Needle Aspiration (TBNA): Past Present and Future, Current Respiratory Medicine Reviews 2014; 10 (3) . https://dx.doi.org/10.2174/1573398X10666141118232214
DOI https://dx.doi.org/10.2174/1573398X10666141118232214 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders
Current Pharmaceutical Design Hypoxia as an Initiator of Neuroinflammation: Microglial Connections
Current Neuropharmacology Role, Function and Therapeutic Potential of microRNAs in Vascular Aging
Current Vascular Pharmacology A Perspective on Clinical Islet Transplantation: Past, Present and Developments for Future
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Tissue Doppler Imaging: Beautiful Noise
Current Cardiology Reviews The Role of Statins for the Primary and Secondary Prevention of Coronary Heart Disease in Women
Current Pharmaceutical Design Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
Current Vascular Pharmacology Effect of Aging On Angiogenesis and Arteriogenesis
Current Cardiology Reviews Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications
Current Pharmaceutical Design The ACE2-Ang-(1-7)-Mas Axis and Cardioprotection
Current Cardiology Reviews Modulation of Transient Receptor Potential Vanilloid Subtype 1 (TRPV<sub>1</sub>) and Norepinephrine Transporters (NET) Protect Against Oxidative Stress, Cellular Injury, and Vascular Dementia
Current Neurovascular Research Therapeutic Approaches in Vascular Repair Induced by Adult Bone Marrow Cells and Circulating Progenitor Endothelial Cells
Current Pharmaceutical Design Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets
Current Medicinal Chemistry Collateral Circulation in Chronic Total Occlusions – an interventional perspective
Current Cardiology Reviews Redox Signaling Pathways Involved in Neuronal Ischemic Preconditioning
Current Neuropharmacology ACE and ACE2 in Inflammation: A Tale of Two Enzymes
Inflammation & Allergy - Drug Targets (Discontinued) Editorial : (Thematic issue: Critical Appraisal of Ischemic Stroke Pathophysiology: Road to Cerebral Resuscitation? Part II)
Current Medicinal Chemistry Erythropoietin: New Approaches to Improved Molecular Designs and Therapeutic Alternatives
Current Pharmaceutical Design Ranolazine, a Partial Fatty Acid Oxidation Inhibitor, its Potential Benefit in Angina and Other Cardiovascular Disorders
Recent Patents on Cardiovascular Drug Discovery